Apply for access
Forgot Password?
Printer Friendly Version Printer-Friendly Version
Submit a comment Comment on this Article

Sakata Seed Corporation President, Mr. Hiroshi Sakata, in Cianjur, West Java Province in Indonesia on September 6th, 2016 honoring Sakata and SunPatiens' agreement with Indonesia. SunPatiens genetics are developed in joint cooperation with Indonesia(IAARD).

Breakthrough Agreement Signed Between Republic of Indonesia (IAARD) and Sakata Seed


Sakata Seed Corporation and the Indonesian government have formally agreed on the utilization of indigenous genetic resources for the further development of SunPatiens®.

This agreement is based on the Convention on Biological Diversity (hereafter, CBD). There are only a few cases known in the world of such an agreement based on CBD in the category of horticultural plants, made between a resource-rich country and a commercial seed company.

SunPatiens® offered by Sakata Seed Corporation, is an assortment of garden flowers that was developed in line with the principles of CBD, in collaboration with the Indonesian Agency for Agricultural Research and Development (IAARD) for access to its native resources. SunPatiens® uses the breeding material of Indonesia’s native species of Impatiens.

In the early 2000s, IAARD and Sakata made a basic agreement for the utilization of this native species and Sakata has been conducting research and development ever since. Starting with this basic agreement, Sakata has been using Indonesian collection of genetic resources of Impatiens by applying material transfer agreement following CBD convention.

SunPatiens® was commercially launched in 2006, and has grown to be recognized worldwide as one of the best performing flowering annuals in its category, especially in Japan, Europe and North and South America. Part of the revenue generated from sales of the product is being allocated based on the agreement for Access and Benefit-Sharing for utilization of genetic resources (hereafter, ABS agreement). Sakata pays a share of the SunPatiens® royalty proceeds to the Indonesian government and, in addition, performs technology transfer as a non-monetary benefit sharing.

In 2014, the two parties updated the collaboration and implemented an innovative joint research project based on the new national measures. In 2016, both parties will continue to collaborate and will proceed with joint research of Indonesia and Sakata that will further contribute to the development of even better cooperative structures for the utilization of genetic resources and the conservation and utilization of biological diversity as an irreplaceable heritage of humankind.

On September 6th, 2016, Sakata and SunPatiens were recognized at the Open House Floriculture event in Cianjur, Indonesia. Mr. Sakata attended the event and the ceremony honored the agreement between Sakata and Indonesia and the positive example it sets for the industry as a whole. 

Read Greenhouse Grower's article on this subject for more information, including an interview with Sakata Seed America President, Dave Armstrong, here.

Why SunPatiens®? Helpful Links! 

Top Crop Page

NEW! SunPatiens POP Materials

SunPatiens Consumer Site

Compact Series

Spreading Series

Vigorous Series

Submit a comment Comment on this Article